{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T18:00:17Z","timestamp":1761933617142,"version":"build-2065373602"},"reference-count":11,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":3212,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:p>A 55\u2010year\u2010old Caucasian woman with a previously documented sulfa allergy was admitted to the hospital after she developed toxic epidermal necrolysis; she had been taking valdecoxib for 8 days for knee pain. Four days later, her bullous lesions had progressed to 45\u201350% of her body surface area. She was transferred to a burn unit for aggressive wound care and fluid hydration. Valdecoxib, a cyclooxygenase\u20102 inhibitor, is a benzenesulfonamide prescribed for arthritis pain and inflammation, and dysmenorrhea. Clinicians should exercise caution when prescribing valdecoxib to patients who are allergic to sulfa drugs.<\/jats:p>","DOI":"10.1592\/phco.23.4.551.32118","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T08:01:46Z","timestamp":1084262506000},"page":"551-553","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Valdecoxib\u2010Induced Toxic Epidermal Necrolysis in a Patient Allergic to Sulfa Drugs"],"prefix":"10.1002","volume":"23","author":[{"given":"Denise L.","family":"Glasser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan H.","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"566","volume-title":"Clinical dermatology","author":"Habif T","year":"1996"},{"key":"e_1_2_1_3_2","unstructured":"G.D. Searle LLC.Bextra (valdecoxib) package insert. Chicago IL:2002."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)87238-0"},{"key":"e_1_2_1_5_2","first-page":"1142","volume-title":"Drug information handbook","author":"Lacy CF","year":"2001"},{"key":"e_1_2_1_6_2","unstructured":"Pharmacia Corporation.Data on file. Peapack NJ;2002."},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124040-00001"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.8.637.33200"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051790"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051569"},{"key":"e_1_2_1_11_2","unstructured":"G.D. Searle & Co.Celebrex (celecoxib) package insert. Skokie IL;2000."},{"key":"e_1_2_1_12_2","unstructured":"Merck & Co.Vioxx (rofecoxib) package insert. Whitehouse Station NJ;2002."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.23.4.551.32118","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.23.4.551.32118","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:44:30Z","timestamp":1761054270000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.23.4.551.32118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1592\/phco.23.4.551.32118"],"URL":"https:\/\/doi.org\/10.1592\/phco.23.4.551.32118","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[2003,4]]},"assertion":[{"value":"2012-01-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}